How Antares Pharma Beat Expectations in Q4
Antares Pharma (NASDAQ: ATRS) finished 2019 on a positive note, with the stock jumping nearly 73% last year. But it's been pretty much all downhill for shares in 2020 so far.
The pharmaceutical technology company's latest quarterly update isn't likely to change things one way or the other. Antares announced its 2019 fourth-quarter and full-year results before the market opened on Tuesday. Here are the highlights from the company's Q4 update.
Image source: Getty Images.
Source Fool.com
